ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2184

A Flexion Contracture Is a Risk Factor for Radiographic Progression and Earlier Need for Arthroplasty in Knee Osteoarthritis: Data from the Osteoarthritis Initiative

T Mark Campbell1 and Dennis McGonagle 2, 1Elisabeth Bruyere Hospital, Ottawa, ON, Canada, 2University of Leeds, Leeds, United Kingdom

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Osteoarthritis, radiographic outcomes and contractures, range of motion

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 12, 2019

Title: Osteoarthritis – Clinical Poster II

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Osteoarthritis (OA) is the most common form of arthritis. Knee OA is often accompanied by a knee flexion contracture (FC), but the impact of FC on OA-related outcomes is not well-described. We evaluated whether the presence and/or severity of a knee FC were risk factors for increased OA incidence, clinical outcomes, radiographic progression and the need for and time to total knee arthroplasty (TKA).

Methods: The cohort design was based on 9-year longitudinal data from the osteoarthritis initiative (OAI) database. Participants (n=4,796) were divided into 3 sub-cohorts: at-risk of knee OA (n=3284), radiographically-established knee OA (n=1390), and low-risk controls (n=122). We categorized knee FCs as none, mild, moderate or severe, based on maximum knee extension at enrollment. The incidence of radiographic knee OA was based on those with Kellgren and Lawrence (KL) score < 2 at enrolment, but ≥2 on follow-up xray. Clinical outcomes (pain, stiffness and function) were evaluated using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scale. KL radiographic scores, and time to TKA were extracted from the database. Effect size of FC was evaluated using a linear mixed regression model.

Results: Participants with knee FC without radiographic OA at enrolment did not have increased incidence of radiographic OA over the duration of data collection. The WOMAC pain, stiffness and function scores were worse in the FC group in a FC severity-dependent manner at nearly all timepoints (Figure 1). Effect estimates were significant for all 3 outcomes comparing FC vs no FC (0.17 [95% C.I. 0.12-0.22]) for pain, 0.12 [95% C.I. 0.09-0.14] for stiffness, 0.64 [95% C.I. 0.48-0.80] for function, all p< 0.001; Table 1). Those with knee FC had higher KL scores across all timepoints (effect size 0.38, p< 0.001, [95% C.I. 0.35-0.41]; Figure 2) with KL scores increasing with worsening FC severity (p< 0.001). Those with FC were more likely to undergo TKA (266/2819 or 9.4% with FC vs 246/5848 or 4.2% without FC, odds ratio 2.4 [95% C.I. 2.0-2.8], p< 0.001; Figure 2). After correcting for demographic variables, cohort, and baseline KL score, FC remained an independent predictor of TKA, in a severity dependent manner (Table 1). A FC was also a risk factor for having a TKA at an earlier timepoint (mean 279 days, p=0.024; Figure 2).

Conclusion: The presence of a knee FC at enrollment was a risk factor for worse clinical outcomes, radiographic progression, need for, and earlier time to TKA. Pain and OA-related structural changes may also lead to knee FC. Further research using MRI to define the anatomic/structural factors that contribute to FC and the link to OA progression are needed. Early and aggressive treatment of a knee FC may represent a treatment option for improving clinical outcomes and slowing OA progression in knee OA. Longitudinal evaluation of such treatment is needed.

Figure 1. Clinical WOMAC outcome scores over 9-year timeline. Top: Pain subscores; middle: stiffness subscores, bottom: function subscores. Left: FC versus no FC; right: scoring by FC severity. All outcomes are worse in the FC group for each timepoint, with the majority following a dose-dependent relationship. FC: flexion contracture. ****p<0.001.

Figure 2. Radiographic scores and time to total knee arthroplasty for OAI participants over 9-year timeline. A- KL radiographic scores for all OAI participants. B- KL radiographic scores for at-risk OAI participants. C- KL radiographic scores for all OAI participants. D- Survival curves showing time to TKA for all OAI participants. For all panels – Left: FC compared to No FC group. Right: groups divided by FC severity. For OAI participants, all radiographic scores were worse over time, and worse for those with FC, in a severity dependent manner. The proportion of participants receiving TKA was increased and time to TKA was reduced for participants with FC, in a severity-dependent manner. FC: flexion contracture; KL: Kellgren and Lawrence. ****p<0.001.


Disclosure: T. Campbell, None; D. McGonagle, AbbVie, 9, Abbvie, 2, 8, BMS, 9, Celgene, 2, 8, 9, Janssen, 2, 8, Johnson & Johnson, 9, Lilly, 2, 8, MSD, 9, Novartis, 2, 8, 9, Pfizer, 2, 8, 9, UCB, 8, 9.

To cite this abstract in AMA style:

Campbell T, McGonagle D. A Flexion Contracture Is a Risk Factor for Radiographic Progression and Earlier Need for Arthroplasty in Knee Osteoarthritis: Data from the Osteoarthritis Initiative [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/a-flexion-contracture-is-a-risk-factor-for-radiographic-progression-and-earlier-need-for-arthroplasty-in-knee-osteoarthritis-data-from-the-osteoarthritis-initiative/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-flexion-contracture-is-a-risk-factor-for-radiographic-progression-and-earlier-need-for-arthroplasty-in-knee-osteoarthritis-data-from-the-osteoarthritis-initiative/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology